Research on Fitness Function of Two Evolution Algorithms Used for Neutron Spectrum Unfolding

Li Rui,Yang Jianbo,Tuo Xianguo,Shi Rui 한국물리학회 2021 THE JOURNAL OF THE KOREAN PHYSICAL SOCIETY Vol.78 No.2

When evolution algorithms are used to unfold the neutron energy spectrum, fitness function design is an important fundamental work for evaluating the quality of the solution, but it has not attracted much attention. In this work, we investigated the performance of eight fitness functions attached to the genetic algorithm (GA) and the differential evolution algorithm (DEA) used for unfolding four neutron spectra selected from the IAEA 403 report. Experiments show that the fitness functions with a maximum in the GA can limit the ability of the population to percept the fitness change, but the ability can be made up in the DEA. The fitness function with a feature penalty term helps to improve the performance of solutions, and the fitness function using the standard deviation and the Chi-squared result shows the balance between the algorithm and the spectra. The results also show that the DEA has good potential for neutron energy spectrum unfolding. The purposes of this work are to provide evidence for structuring and modifying the fitness functions and to suggest some genetic operations that should receive attention when using the fitness function to unfold neutron spectra.

Polyaniline-modified graphitic carbon nitride as electrode materials for high-performance supercapacitors

Qin Xin,Wan Jianbo,Zhang Qi,Zhang Yongjie,Yu Huangzhong,Shi Shengwei 한국탄소학회 2023 Carbon Letters Vol.33 No.3

Graphitic carbon nitride (g-C3N4) has attracted extensive attention in energy storage due to its suitable and tunable bandgap, high chemical/thermal stability, earth abundance and environmental friendliness. However, its conductivity should be improved to work as the electrode materials in supercapacitors. In this report, we have prepared a two-dimensional composite (CN-PANI) based on g-C3N4 and polyaniline (PANI) by in-situ polymerization, which can be efficiently applied as electrode material for supercapacitors. The introduction of PANI can increase the conductivity of the electrode, and the porous structure of g-C3N4 can provide enough channels for the transport of electrolyte ions and improve the electrode stability. As a result, the obtained CN-PANI demonstrates excellent specific capacitance (234.0 F g−1 at 5 mV/s), good rate performance and high cycling stability (86.2% after 10,000 cycles at 50 mV/s), showing great potential for high-rate supercapacitors.

Application of response surface methodology to the decolorization by the electrochemical process using FePMo12O40 catalyst

Lin Yue,Li Wang,Feng Shi,Jianbo Guo,Jingliang Yang,Jing Lian,Xiao Luo 한국공업화학회 2015 Journal of Industrial and Engineering Chemistry Vol.21 No.1

In order to optimize the experimental conditions, the decolorization of Acid Red 3R by electrochemicaloxidation process with catalyst FePMo12-APS-MS4A as packing was performed using response surfacemethodology (RSM). The microstructure and morphology of FePMo12-APS-MS4A were characterizedwith Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), scanning electronmicroscopy (SEM) and X-ray fluorescence spectroscopy (XRF). Four control factors were throughlyanalyzed by means of RSM based on Box–Behnken design (BBD). Taking the decolorization efficiency asresponse value, a second order polynomial model was established. The model and analysis stronglyindicated that the cell voltage and airflow caused positive, and the initial pH and inter-electrode distancecaused negative effect on the decolorization efficiency. The interaction between cell voltage and initialpH, initial pH and airflow were also revealed. Under the optimal conditions, the color, COD and TOCremoval efficiency reached 67.3%, 58.4% and 47.9% after 60 min. Liquid chromatography–massspectrometry (LC–MS) analysis revealed that the dye molecule underwent a series of reduction andoxidation steps, including azo bond fracture, desulfonation and denitrogenation. The possiblemechanisms involving in this reaction process were proposed.

Risk Factors and Characteristics of the Recurrence of Juvenile Nasopharyngeal Angiofibroma: A 22-Year Experience With 123 Cases at a Tertiary Center

Ruihua Fang,Jian Li,Weiping Wen,Wei Sun,Rui Xu,Jianbo Shi,Liang Peng,Yinyan Lai,Fenghong Chen,Yihui Wen 대한이비인후과학회 2022 Clinical and Experimental Otorhinolaryngology Vol.15 No.4

Objectives. Despite the efficacy of surgical treatments, the high rate of recurrence in juvenile nasopharyngeal angiofibroma (JNA) after surgery remains an unresolved problem. The present study comprehensively analyzed the risk factors and characteristics of JNA recurrence, providing clinical guidance for reducing recurrence. Methods. A total of 123 patients who underwent surgery for JNA between 1997 and 2019 at a single hospital were analyzed retrospectively. Univariate and multivariate analyses were used to assess the clinical risk factors for the recurrence of JNA. The relapse-free survival and annual cumulative recurrence rates were analyzed for subgroups defined according to clinical parameters. Results. After screening, 78 of the 123 patients were included in the present study. The main risk factors associated with JNA recurrence included the year of diagnosis, tumor size, sphenoid bone invasion, Radkowski stage, surgical approach, and intraoperative bleeding. Importantly, the surgical approach and sphenoid bone invasion were independent prognostic factors affecting recurrence. Patients who underwent endoscopic surgery without sphenoid bone invasion exhibited longer relapse-free survival. In the present study, the overall cumulative recurrence rate of JNA was 38.7%, and recurrence occurred mainly in the first year after the initial surgery. Conclusion. Endoscopic surgery achieved better relapse-free survival in JNA patients, and patients with sphenoid bone invasion should be carefully explored to avoid residual JNA. The recurrence rate of JNA differed among subgroups defined based on clinical parameters and was highest in the first year after surgery. Computed tomography or magnetic resonance imaging, along with close follow-up, should be performed strictly within 1 year after the primary operation.

Chinese Society of Allergy and Chinese Society of Otorhinolaryngology-Head and Neck Surgery Guideline for Chronic Rhinosinusitis

Zheng Liu,Jianjun Chen,Lei Cheng,Huabin Li,Shixi Liu,Hongfei Lou,Jianbo Shi,Ying Sun,Dehui Wang,Chengshuo Wang,Xiangdong Wang,Yongxiang Wei,Weiping Wen,Pingchang Yang,Qintai Yang,Gehua Zhang,Yuan Zhan 대한천식알레르기학회 2020 Allergy, Asthma & Immunology Research Vol.12 No.2

The current document is based on a consensus reached by a panel of experts from the Chinese Society of Allergy and the Chinese Society of Otorhinolaryngology-Head and Neck Surgery, Rhinology Group. Chronic rhinosinusitis (CRS) affects approximately 8% of Chinese adults. The inflammatory and remodeling mechanisms of CRS in the Chinese population differ from those observed in the populations of European descent. Recently, precision medicine has been used to treat inflammation by targeting key biomarkers that are involved in the process. However, there are no CRS guidelines or a consensus available from China that can be shared with the international academia. The guidelines presented in this paper cover the epidemiology, economic burden, genetics and epigenetics, mechanisms, phenotypes and endotypes, diagnosis and differential diagnosis, management, and the current status of CRS in China. These guidelines—with a focus on China—will improve the abilities of clinical and medical staff during the treatment of CRS. Additionally, they will help international agencies in improving the verification of CRS endotypes, mapping of eosinophilic shifts, the identification of suitable biomarkers for endotyping, and predicting responses to therapies. In conclusion, these guidelines will help select therapies, such as pharmacotherapy, surgical approaches and innovative biotherapeutics, which are tailored to each of the individual CRS endotypes.

Expression and Regulation of Transcription Factor FoxA2 in Chronic Rhinosinusitis With and Without Nasal Polyps

Qing Luo,Jia Zhang,Hongtian Wang,Fenghong Chen,Xi Luo,Beiping Miao,Xingmei Wu,Renqiang Ma,Xiangqian Luo,Geng Xu,Jianbo Shi,Huabin Li 대한천식알레르기학회 2015 Allergy, Asthma & Immunology Research Vol.7 No.5

Purpose: Chronic rhinosinusitis (CRS) is characterized by the excessive production of mucus. However, the molecular mechanism underlying mucin overproduction in CRS with or without nasal polyps (CRSwNP and CRSsNP, respectively) is poorly understood. This study was conducted to assess the importance of the transcription factor FoxA2 in mucin production and to investigate the targeting of FoxA2 as a potential therapeutic strategy for mucus hypersecretion in CRS patients. Methods: We enrolled 15 CRSwNP patients, 15 CRSsNP patients, and 10 normal controls in this study. The expression levels of FoxA2, MUC5AC, and MUC5B in inflamed and healthy nasal tissues were examined via immunohistochemistry and quantitative reverse transcription-polymerase chain reaction, and the levels of several proinflammatory cytokines in nasal secretions were measured via FlowCytomix analysis. In addition, the expression of MUC5AC and FoxA2 was determined in polyp-derived epithelial cells and NCI-H292 cells after in vitro stimulation. Results: FoxA2 was significantly down-regulated, and MUC5AC and MUC5B were significantly up-regulated in both the CRSwNP and CRSsNP patients compared to the controls (P<0.05), and the protein level of FoxA2 was negatively associated with the IL-6 level in the CRS patients (P<0.05). IL-6 significantly increased MUC5AC expression but inhibited FoxA2 expression in vitro (P<0.05). Transfection with a FoxA2 expression plasmid significantly decreased MUC5AC promoter activity (P<0.05) and inhibited IL-6-induced MUC5AC production (P<0.05). In addition, clarithromycin significantly alleviated IL-6-induced FoxA2 suppression and decreased MUC5AC expression in vitro (P<0.05). Conclusions: Our findings suggest that FoxA2 may be considered a therapeutic target for the modulation of mucus hypersecretion in CRS patients.